b12 injections and chemo Timing of folic acid/vitamin supplementation hematologic toxicity during first‐line treatment of patients with nonsquamous non–small cell lung cancer using pemetrexed‐based chemotherapy: The PEMVITASTART randomized trial - Singh MIC+B12 | Energy + Mood

Pemetrexed for Injection, USP Brand Name Equivalent: Alimta Pemetrexed for Injection, USP 100 mg per vial Unit of Sale NDC 71288-166-10 Unit of Use NDC 71288-166-10 Container Type SD Glass Vial Strength 100 mg per vial Concentration N/A Fill Volume N/A Vial Size 10 mL Closure 20 mm Units of Sale 1 Pack (1 X 1) Minimum Order 1 Case (108 X 1) Product Information Preservative Free Not made with natural rubber latex AP Rated Pemetrexed for Injection, USP 500 mg per vial Unit of Sale NDC 71288-167-50 Unit of Use NDC 71288-167-50 Container Type SD Glass Vial Strength 500 mg per vial Concentration N/A Fill Volume N/A Vial Size 50 mL Closure 20 mm Units of Sale 1 Pack (1 X 1) Minimum Order 1 Case (108 X 1) Product Information Preservative Free Not made with natural rubber latex AP Rated Pemetrexed for Injection, USP 750 mg per vial Unit of Sale NDC 71288-147-50 Unit of Use NDC 71288-147-50 Container Type SD Glass Vial Strength 750 mg per vial Concentration N/A Fill Volume N/A Vial Size 50 mL Closure 20 mm Units of Sale 1 Pack (1 X 1) Minimum Order 1 Pack (1 X 1) Product Information Preservative Free Not made with natural rubber latex AP Rated Pemetrexed for Injection, USP 1 g per vial Unit of Sale NDC 71288-148-51 Unit of Use NDC 71288-148-51 Container Type SD Glass Vial Strength 1 g per vial Concentration N/A Fill Volume N/A Vial Size 100 mL Closure 20 mm Units of Sale 1 Pack (1 X 1) Minimum Order 1 Pack (1 X 1) Product Information Preservative Free Not made with natural rubber latex AP Rated The brands mentioned here are the trademarks of their respective owners

This affordable supplement is designed to fulfill the body's nutritional needs and is safe for long-term use

Fast Delivery

common reactions include transient pain, erythema, or pruritus at the administration site, along with mild diarrhea, headache, or nausea in a minority of recipients